Doklinicheskaia otsenka bezopasnosti iodantipirina.

Translated title of the contribution: A preclinical trial of iodoantipyrine safety

A. S. Saratikov, T. P. Novozheeva, N. S. Livshits, F. I. Burchenkova, N. G. Kadychagova, R. R. Akhmedzhanov, L. V. Bashirova, A. A. Eremina, G. V. Potapova

Research output: Contribution to journal › Article

Abstract

Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.

Original languageRussian
Pages (from-to)57-59
Number of pages3
JournalEksperimental'naia i klinicheskaia farmakologiia
Volume61
Issue number2
Publication statusPublished - Mar 1998

Fingerprint

Poisons
Lethal Dose 50
Antiviral Agents
Rats
Dogs
Safety
Pharmaceutical Preparations
iodoantipyrine

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Saratikov, A. S., Novozheeva, T. P., Livshits, N. S., Burchenkova, F. I., Kadychagova, N. G., Akhmedzhanov, R. R., ... Potapova, G. V. (1998). Doklinicheskaia otsenka bezopasnosti iodantipirina. Eksperimental'naia i klinicheskaia farmakologiia, 61(2), 57-59.

Doklinicheskaia otsenka bezopasnosti iodantipirina. / Saratikov, A. S.; Novozheeva, T. P.; Livshits, N. S.; Burchenkova, F. I.; Kadychagova, N. G.; Akhmedzhanov, R. R.; Bashirova, L. V.; Eremina, A. A.; Potapova, G. V.

In: Eksperimental'naia i klinicheskaia farmakologiia, Vol. 61, No. 2, 03.1998, p. 57-59.

Research output: Contribution to journal › Article

Saratikov, AS, Novozheeva, TP, Livshits, NS, Burchenkova, FI, Kadychagova, NG, Akhmedzhanov, RR, Bashirova, LV, Eremina, AA & Potapova, GV 1998, 'Doklinicheskaia otsenka bezopasnosti iodantipirina.', Eksperimental'naia i klinicheskaia farmakologiia, vol. 61, no. 2, pp. 57-59.
Saratikov AS, Novozheeva TP, Livshits NS, Burchenkova FI, Kadychagova NG, Akhmedzhanov RR et al. Doklinicheskaia otsenka bezopasnosti iodantipirina. Eksperimental'naia i klinicheskaia farmakologiia. 1998 Mar;61(2):57-59.
Saratikov, A. S. ; Novozheeva, T. P. ; Livshits, N. S. ; Burchenkova, F. I. ; Kadychagova, N. G. ; Akhmedzhanov, R. R. ; Bashirova, L. V. ; Eremina, A. A. ; Potapova, G. V. / Doklinicheskaia otsenka bezopasnosti iodantipirina. In: Eksperimental'naia i klinicheskaia farmakologiia. 1998 ; Vol. 61, No. 2. pp. 57-59.
@article{b8da7b22bc97444389577dd3f301751f,
title = "Doklinicheskaia otsenka bezopasnosti iodantipirina.",
abstract = "Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.",
author = "Saratikov, {A. S.} and Novozheeva, {T. P.} and Livshits, {N. S.} and Burchenkova, {F. I.} and Kadychagova, {N. G.} and Akhmedzhanov, {R. R.} and Bashirova, {L. V.} and Eremina, {A. A.} and Potapova, {G. V.}",
year = "1998",
month = "3",
language = "Русский",
volume = "61",
pages = "57--59",
journal = "Eksperimental'naya i Klinicheskaya Farmakologiya",
issn = "0869-2092",
publisher = "Izdatelstvo Meditsina",
number = "2",

}

TY - JOUR

T1 - Doklinicheskaia otsenka bezopasnosti iodantipirina.

AU - Saratikov, A. S.

AU - Novozheeva, T. P.

AU - Livshits, N. S.

AU - Burchenkova, F. I.

AU - Kadychagova, N. G.

AU - Akhmedzhanov, R. R.

AU - Bashirova, L. V.

AU - Eremina, A. A.

AU - Potapova, G. V.

PY - 1998/3

Y1 - 1998/3

N2 - Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.

AB - Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.

UR - http://www.scopus.com/inward/record.url?scp=0032016077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032016077&partnerID=8YFLogxK

M3 - Статья

C2 - 9621178

VL - 61

SP - 57

EP - 59

JO - Eksperimental'naya i Klinicheskaya Farmakologiya

JF - Eksperimental'naya i Klinicheskaya Farmakologiya

SN - 0869-2092

IS - 2

ER -

Access to Document